{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:06:19Z","timestamp":1777485979150,"version":"3.51.4"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002066","name":"GSK","doi-asserted-by":"publisher","award":["207965"],"award-info":[{"award-number":["207965"]}],"id":[{"id":"10.13039\/501100002066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ashfield MedComms"},{"name":"Inizio company"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Antibiotic susceptibility determination of community-acquired respiratory tract infection (CA-RTI) isolates of Streptococcus pneumoniae and Haemophilus influenzae were collected from India (2018\u201321).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MICs were determined by CLSI broth microdilution; susceptibility data were interpreted using CLSI, EUCAST and pharmacokinetic\/pharmacodynamic (PK\/PD) breakpoints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>S. pneumoniae (n\u200a=\u200a177) and H. influenzae (n\u200a=\u200a171) isolates were collected from four hospital laboratories and two private laboratories in India. Only 41.2% pneumococci were penicillin susceptible by CLSI oral\/EUCAST low-dose breakpoints, but 94.4% were susceptible by EUCAST high-dose\/CLSI IV breakpoints. Good activity (\u226589.8%, CLSI or PK\/PD breakpoints) was observed for amoxicillin, amoxicillin\/clavulanic acid, cefotaxime, ceftriaxone, levofloxacin, and moxifloxacin. Cefdinir and second-generation cephalosporins were less active (27.7%\u201364.4%). Tetracyclines, macrolides and trimethoprim\/sulfamethoxazole showed poor activity (18.6%\u201331.1%). EUCAST breakpoints indicated &amp;gt;90% susceptibility to high-dose ceftriaxone and penicillin, moxifloxacin and high-dose levofloxacin. Lower susceptibility to other cephalosporins and aminopenicillins was observed with EUCAST versus CLSI or PK\/PD breakpoints. Most H. influenzae isolates (91.8%) were \u03b2-lactamase negative; 13 and 5 were \u03b2-lactamase-negative ampicillin-resistant following EUCAST and CLSI criteria, respectively. Antibiotic susceptibility was \u226584.8% (CLSI) for all antibiotics except trimethoprim\/sulfamethoxazole (23.4%). Susceptibility by EUCAST was similar, except for cefuroxime (oral) with no susceptible isolates versus 95.3% by CLSI and \u226429.8% versus \u226585.4% for fluoroquinolones.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Some therapeutic options against S. pneumoniae and H. influenzae from CA-RTI in India remain, but only ceftriaxone covers both bacterial species using both guidelines. Continued surveillance of antibiotic susceptibility is important to monitor changes and trends in susceptibilities and for guiding empiric therapy of CA-RTIs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkaf285","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T11:52:01Z","timestamp":1753271521000},"page":"iii38-iii52","source":"Crossref","is-referenced-by-count":1,"title":["Results from the Survey of Antibiotic Resistance (SOAR) 2018\u201321 in India: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic\/pharmacodynamic (PK\/PD) breakpoints"],"prefix":"10.1093","volume":"80","author":[{"given":"Didem","family":"Torumkuney","sequence":"first","affiliation":[{"name":"Infectious Diseases Research Unit, GSK , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balaji","family":"Veeraraghavan","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Christian Medical College , Vellore ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niranjan","family":"Patil","sequence":"additional","affiliation":[{"name":"Microbiology and Infectious Molecular Biology, Metropolis Healthcare Private Limited , Vidyavihar West, Mumbai ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Dias","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Division of Infectious Diseases, St John's Medical College Hospital , Bangalore ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeti","family":"Maheshwari","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Sciences, Toprani Advanced Lab Systems , Vadodara ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar Narayan","family":"Chaudhuri","sequence":"additional","affiliation":[{"name":"Microbiology Research Center LTD, Peerless Hospital , Kolkata ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ujjwayini","family":"Ray","sequence":"additional","affiliation":[{"name":"Consultant, Apollo Multispecialty Hospitals , Kolkata ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Hawser","sequence":"additional","affiliation":[{"name":"Global Affairs, IHMA Europe S\u00e0rl , Monthey ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhashri","family":"Kundu","sequence":"additional","affiliation":[{"name":"Infectious Diseases - Antibiotic Resistance, GSK , , Republic of Singapore","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Manoharan","sequence":"additional","affiliation":[{"name":"Infectious Diseases Medical & Scientific Affairs, GSK , Mumbai ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2025112403093516400_dkaf285-B1","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(21)00630-9","article-title":"Community-acquired pneumonia","volume":"398","author":"Aliberti","year":"2021","journal-title":"Lancet"},{"key":"2025112403093516400_dkaf285-B2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/MCC.0000000000000550","article-title":"Community-acquired pneumonia as an emergency condition","volume":"24","author":"Cill\u00f3niz","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"2025112403093516400_dkaf285-B3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4103\/ijp.ijp_976_21","article-title":"Assessment of prescribing pattern of drugs and completeness of prescriptions as per the World Health Organization prescribing indicators in various Indian tertiary care centers: a multicentric study by Rational Use of Medicines Centers-Indian Council of Medical Research network under National Virtual Centre Clinical Pharmacology activity","volume":"54","author":"Joshi","year":"2022","journal-title":"Indian J Pharmacol"},{"key":"2025112403093516400_dkaf285-B4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1471-2334-11-99","article-title":"Trends in antibiotic use among outpatients in New Delhi, India","volume":"11","author":"Kotwani","year":"2011","journal-title":"BMC Infect Dis"},{"key":"2025112403093516400_dkaf285-B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/bcp.13503","article-title":"Threats to global antimicrobial resistance control: centrally approved and unapproved antibiotic formulations sold in India","volume":"85","author":"McGettigan","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"2025112403093516400_dkaf285-B6","doi-asserted-by":"publisher","first-page":"e33917","DOI":"10.7759\/cureus.33917","article-title":"Prevalence, pattern, and reasons for self-medication: a community-based cross-sectional study from central India","volume":"15","author":"Rathod","year":"2023","journal-title":"Cureus"},{"key":"2025112403093516400_dkaf285-B7","doi-asserted-by":"publisher","first-page":"k3047","DOI":"10.1136\/bmj.k3047","article-title":"Advances in optimizing the prescription of antibiotics in outpatient settings","volume":"363","author":"King","year":"2018","journal-title":"BMJ"},{"key":"2025112403093516400_dkaf285-B8","doi-asserted-by":"publisher","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112403093516400_dkaf285-B9","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.4103\/jfmpc.jfmpc_275_19","article-title":"India's National Action Plan for antimicrobial resistance\u2014an overview of the context, status, and way ahead","volume":"8","author":"Ranjalkar","year":"2019","journal-title":"J Family Med Prim Care"},{"key":"2025112403093516400_dkaf285-B10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"2025112403093516400_dkaf285-B11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/cid\/civ1214","article-title":"Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia","volume":"62","author":"Gadsby","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025112403093516400_dkaf285-B12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/17476348.2019.1562339","article-title":"The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance","volume":"13","author":"Peyrani","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"2025112403093516400_dkaf285-B13","doi-asserted-by":"publisher","first-page":"e000214","DOI":"10.1099\/mgen.0.000214","article-title":"The return of Pfeiffer's bacillus: rising incidence of ampicillin resistance in Haemophilus influenzae","volume":"4","author":"Heinz","year":"2018","journal-title":"Microb Genom"},{"key":"2025112403093516400_dkaf285-B14"},{"key":"2025112403093516400_dkaf285-B15","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1093\/jac\/dkw332","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2012\u201314 in Thailand, India, South Korea and Singapore","volume":"71","author":"Torumkuney","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2025112403093516400_dkaf285-B16","author":"CLSI"},{"key":"2025112403093516400_dkaf285-B17","author":"CLSI"},{"key":"2025112403093516400_dkaf285-B18","author":"European Committee on Antimicrobial Susceptibility Testing"},{"issue":"Suppl 1","key":"2025112403093516400_dkaf285-B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.otohns.2003.12.003","article-title":"Antimicrobial treatment guidelines for acute bacterial rhinosinusitis","volume":"130","author":"Anon","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"Suppl 1","key":"2025112403093516400_dkaf285-B20","doi-asserted-by":"publisher","first-page":"i10","DOI":"10.1093\/jac\/dkac212","article-title":"Country data on AMR in India in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome","volume":"77","author":"Torumkuney","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2025112403093516400_dkaf285-B21","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1128\/AAC.43.8.1862","article-title":"Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents","volume":"43","author":"Johnson","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2025112403093516400_dkaf285-B22","doi-asserted-by":"publisher","first-page":"e21437","DOI":"10.7759\/cureus.21437","article-title":"Antimicrobial susceptibility pattern and serotype distribution of Streptococcus pneumoniae isolates from a hospital-based study in Chandigarh, North India","volume":"14","author":"Sharma","year":"2022","journal-title":"Cureus"},{"issue":"3&4","key":"2025112403093516400_dkaf285-B23","doi-asserted-by":"publisher","first-page":"354","DOI":"10.25259\/ijmr_1811_23","article-title":"Pre- & post-vaccine trends in pneumococcal serotypes & antimicrobial resistance patterns","volume":"160","author":"Peela","year":"2024","journal-title":"Indian J Med Res"},{"key":"2025112403093516400_dkaf285-B24","author":"Pfizer"},{"key":"2025112403093516400_dkaf285-B25","author":"European Committee on Antimicrobial Susceptibility Testing"},{"key":"2025112403093516400_dkaf285-B26","author":"Manoharan"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/Supplement_3\/iii38\/65487255\/dkaf285.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/Supplement_3\/iii38\/65487255\/dkaf285.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T08:09:42Z","timestamp":1763971782000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/80\/Supplement_3\/iii38\/8340894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":26,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2025,11,24]]},"published-print":{"date-parts":[[2025,11,24]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaf285","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,9]]}}}